ROMSTIM 250 MCG

Romstim 250 mcg powder for Injection 1’s is classified as a ‘platelet-stimulating agent’ and is primarily utilized to manage chronic immune thrombocytopenia in adults who have not adequately responded to corticosteroids, immunoglobulins, or splenectomy. Immune thrombocytopenia, commonly referred to as idiopathic thrombocytopenic purpura (ITP), is an immune disorder marked by reduced platelet counts.

Romstim 250 mcg powder for Injection 1’s contains ‘Romiplostim,’ a thrombopoietin receptor agonist that mimics the action of thrombopoietin. This medication enhances platelet production by stimulating the thrombopoietin receptor, thereby effectively aiding in the treatment of immune thrombocytopenia.

Administration of Romstim 250 mcg powder for Injection 1’s will be carried out by a healthcare professional. Common side effects may include headache, joint pain, dizziness, sleep disturbances, muscle tenderness or weakness, pain in the limbs, and indigestion. These side effects can vary from person to person. Most of these effects do not necessitate medical intervention and will typically resolve on their own over time. However, it is advisable to consult your doctor if these side effects persist.

Inform your doctor if you experience any allergic reactions to Romstim 250 mcg powder for Injection 1’s or other medications. It is crucial to disclose any history of leukaemia (blood or bone marrow cancer), bleeding or clotting disorders, or issues related to the heart, kidneys, or liver. Romstim 250 mcg powder for Injection 1’s is generally not recommended during pregnancy unless prescribed by a physician. This medication may cause dizziness; therefore, it is important to drive or operate machinery only when fully alert. Additionally, Romstim 250 mcg powder for Injection 1’s is not advised for use while breastfeeding.